Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Millstream Acquisition Corp. was a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, or similar business combination. While the company maintained a broad mandate, it specifically targeted businesses within the technology and healthcare sectors. Led by a management team with experience in corporate finance and legal sectors, the entity sought to identify high-growth opportunities that could benefit from the public markets. However, the company failed to complete a business combination within its allotted timeframe and subsequently liquidated its assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Millstream Acquisition.